Medikit Co (TSE:7749) Research & Development: 円0 Mil (TTM As of Dec. 2025)


TSE:7749 Medikit Co Ltd TSE:7749
81 GF Score
Price 円2,805.00
GF Value 円3,281.26
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medikit Co Research & Development?

Medikit Co TSE:7749 -0.18% 81 Research & Development is 円0 Mil as of Dec. 2025. GuruFocus rates TSE:7749 with a GF Score™ of 81/100 and a GF Value™ of 円3,281.26 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Medikit Co's Research & Development for the three months ended in Dec. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was 円0 Mil.


Medikit Co  (TSE:7749) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Medikit Co Research & Development Related Terms


Medikit Co Research & Development Historical Data

* Premium members only.

The historical data trend for Medikit Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medikit Co Research & Development Chart

Medikit Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medikit Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:7749
81GF Score
Medikit Co Ltd TSE:7749
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medikit Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Medikit Co (TSE:7749) has a Research & Development of 円0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Medikit Co and its competitors.
Is Medikit Co's Research & Development too high?
Medikit Co's current Research & Development is 円0 Mil. Overall, Medikit Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medikit Co's Research & Development compare to ISRG and BDX?
Medikit Co's Research & Development of 円0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Medikit Co and its competitors. Medikit Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medikit Co stock overvalued right now?
Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,281.26, compared to a current price of 円2,805.00 — trading 14.5% below its estimated fair value. The current Research & Development is 円0 Mil. Medikit Co's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current Research & Development is 円0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medikit Co (TSE:7749) Overvalued in 2026?

Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued. The current stock price of 円2,805.00 is trading 14.5% below its estimated GF Value™ of 円3,281.26. GuruFocus considers Medikit Co to be Modestly Undervalued.

Key valuation signals for TSE:7749:

  • Research & Development: 円0 Mil
  • GF Value™: 円3,281.26 vs. price of 円2,805.00 (14.5% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medikit Co Business Description

Address 1-13-2 ,Yushima, Bunkyo-Ku, Tokyo, JPN, 113 0034
Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.
81GF Score

Get the complete analysis for TSE:7749

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,805.00
Price
円3,281.26
GF Value